CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 37.370
AS - Asia 21.236
EU - Europa 18.556
SA - Sud America 4.736
AF - Africa 573
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 40
Totale 82.554
Nazione #
US - Stati Uniti d'America 36.677
SG - Singapore 7.452
CN - Cina 6.962
UA - Ucraina 5.129
BR - Brasile 4.022
IT - Italia 3.498
HK - Hong Kong 2.860
DE - Germania 2.615
PL - Polonia 1.443
FI - Finlandia 1.303
VN - Vietnam 1.267
GB - Regno Unito 1.112
TR - Turchia 970
RU - Federazione Russa 914
IE - Irlanda 868
IN - India 546
FR - Francia 495
SE - Svezia 415
CA - Canada 348
AR - Argentina 274
BD - Bangladesh 244
MX - Messico 223
ZA - Sudafrica 166
AT - Austria 163
IQ - Iraq 145
NL - Olanda 136
ID - Indonesia 129
EC - Ecuador 121
ES - Italia 112
JP - Giappone 89
PK - Pakistan 84
CO - Colombia 81
BE - Belgio 78
SA - Arabia Saudita 72
BF - Burkina Faso 71
UZ - Uzbekistan 57
PY - Paraguay 56
MA - Marocco 55
VE - Venezuela 55
CZ - Repubblica Ceca 54
MU - Mauritius 52
LT - Lituania 49
CL - Cile 40
EU - Europa 38
KE - Kenya 38
AU - Australia 37
JO - Giordania 37
EG - Egitto 36
IR - Iran 34
UY - Uruguay 33
IL - Israele 31
AE - Emirati Arabi Uniti 30
AZ - Azerbaigian 29
PE - Perù 29
ET - Etiopia 27
GH - Ghana 26
JM - Giamaica 26
CR - Costa Rica 21
PH - Filippine 20
PT - Portogallo 20
TN - Tunisia 20
MY - Malesia 19
AL - Albania 18
HN - Honduras 18
NP - Nepal 17
BO - Bolivia 16
CH - Svizzera 16
KZ - Kazakistan 16
DZ - Algeria 15
RO - Romania 15
PA - Panama 14
LB - Libano 13
OM - Oman 13
TT - Trinidad e Tobago 12
BH - Bahrain 11
KR - Corea 11
CM - Camerun 10
DO - Repubblica Dominicana 10
KG - Kirghizistan 9
LK - Sri Lanka 9
SK - Slovacchia (Repubblica Slovacca) 9
BG - Bulgaria 8
BY - Bielorussia 8
CI - Costa d'Avorio 8
GR - Grecia 8
HR - Croazia 8
MD - Moldavia 8
RS - Serbia 8
BB - Barbados 7
NG - Nigeria 7
NI - Nicaragua 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
EE - Estonia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
QA - Qatar 6
SI - Slovenia 6
SN - Senegal 6
TH - Thailandia 6
Totale 82.436
Città #
Singapore 3.636
Jacksonville 3.635
Fairfield 3.587
Woodbridge 2.881
Hong Kong 2.850
Ashburn 2.840
Chandler 2.141
Wilmington 2.002
Houston 1.768
Princeton 1.601
Cambridge 1.467
Ann Arbor 1.464
Seattle 1.449
Warsaw 1.427
Beijing 1.401
Nanjing 1.231
New York 987
Dublin 857
Istanbul 775
Los Angeles 749
Helsinki 562
The Dalles 552
Ho Chi Minh City 443
Munich 443
Nanchang 426
Buffalo 406
Des Moines 406
Brescia 381
São Paulo 358
Moscow 319
Shenyang 316
Milan 301
Changsha 294
Hebei 264
Dallas 245
Hanoi 238
San Diego 235
Tianjin 234
Chicago 219
Jinan 210
Dearborn 202
Jiaxing 196
Redondo Beach 195
Shanghai 185
San Francisco 172
Nuremberg 150
London 148
Kunming 144
Hangzhou 140
Rio de Janeiro 132
Verona 121
Turku 116
Boardman 113
Toronto 109
Santa Clara 100
Kocaeli 94
Mexico City 94
Rome 94
Brooklyn 88
Montreal 87
Zhengzhou 86
Mcallen 83
Tokyo 83
Guangzhou 82
Johannesburg 81
Belo Horizonte 80
Denver 79
Ningbo 78
Brussels 76
Brasília 74
Phoenix 73
Stockholm 70
Lanzhou 69
Orem 68
Vienna 68
Ouagadougou 66
Lancaster 65
Boston 63
Salt Lake City 63
Haiphong 62
Romola 61
Atlanta 58
Chennai 58
Dong Ket 58
Poplar 58
Norwalk 56
Curitiba 55
Jakarta 54
Tashkent 54
Porto Alegre 53
Frankfurt am Main 51
Washington 49
Guarulhos 47
Manchester 46
Taizhou 46
Baghdad 45
Pune 45
Da Nang 44
Düsseldorf 44
Charlotte 43
Totale 50.774
Nome #
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 406
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 396
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 281
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 278
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 253
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 251
Cos’è la Medicina Tropicale 246
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 225
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data 223
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 218
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 217
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 216
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 211
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 207
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 204
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 203
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 201
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 197
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 197
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 192
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 190
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 189
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 186
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 185
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 182
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 181
Towards tuberculosis elimination: An action framework for low-incidence countries 180
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 179
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 178
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 173
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 172
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 168
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 168
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 167
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 163
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 162
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 162
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 162
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 162
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 161
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 161
Non-typhoidal Salmonella aortitis 161
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 160
Louse-borne relapsing fever in a refugee from Mali 158
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 157
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 157
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 157
Accidental and transfusion malaria in Italy 156
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 155
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 155
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 154
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 154
Migration Medicine: the Challenge of Tuberculosis 153
Epidemiology of malaria in endemic areas 153
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 152
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 151
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 151
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 151
Advances in the treatment of malaria 150
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 150
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 148
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 147
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 147
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 147
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 147
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 147
Mapping the human genetic architecture of COVID-19 146
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 146
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 146
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 146
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 146
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 145
Correction to: Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh. 145
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 145
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 144
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 144
Peripheral loss of regulatory T cells and polyautoimmunity in an HIV-infected patient 144
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 144
A Case of Rickettsia felis Infection Imported from Nepal 143
Differential diagnosis of illness in travelers arriving from sierra Leone, Liberia, or guinea: A cross-sectional study from the Geosentinel surveillance network 143
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 143
Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean 143
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 142
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 142
A COPD case-finding program in a large cohort of HIV-infected persons 142
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 141
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 141
Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life 140
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from Non-EU countries in northern Italy 139
Simultaneous Diagnosis of Acute Crohn's Disease and Endometriosis in a Patient Affects HIV 139
Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 138
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 138
A first update on mapping the human genetic architecture of COVID-19 137
Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis 137
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 137
Aetiology of acute gastro-enteritis in children at Saint Camille Medical Centre, Ouagadougou, Burkina Faso 137
Algorithm based management of pneumonia in HIV-1 infected patients 136
New italian guidelines for malaria prophylaxis in travellers to endemic areas 136
Travel-associated sexually transmitted infections: An observational cross-sectional study of the GeoSentinel surveillance database 136
The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients 136
Totale 17.078
Categoria #
all - tutte 440.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 440.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.625 0 0 0 0 0 1.217 300 1.170 1.528 1.012 1.098 300
2021/20225.841 307 1.166 114 395 89 327 250 459 330 693 506 1.205
2022/20236.001 918 106 104 597 541 1.597 18 623 927 50 232 288
2023/20245.249 378 176 396 331 222 926 176 205 1.326 69 108 936
2024/202514.206 121 74 132 1.544 1.695 1.230 1.297 596 1.556 1.247 2.930 1.784
2025/202616.845 2.578 3.709 2.113 4.285 2.602 1.558 0 0 0 0 0 0
Totale 83.658